Read More 1 minute read Analyst Ratings News Upgrades Benchmark Upgrades Western Digital to Hold By Benzinga Newsdesk Today, 4:08 AM Benchmark analyst Mark Miller upgrades Western Digital (NASDAQ:WDC) from Sell to Hold. WDC
Read More 1 minute read Analyst Ratings News Price Target Upgrades Wells Fargo Upgrades SunPower to Equal-Weight, Announces $21 Price Target By Benzinga Newsdesk Today, 4:08 AM Wells Fargo analyst Michael Blum upgrades SunPower (NASDAQ:SPWR) from Underweight to Equal-Weight and announces $21 price target. SPWR
Read More 1 minute read Analyst Ratings News Price Target Upgrades Wells Fargo Upgrades Stitch Fix to Equal-Weight, Announces $4 Price Target By Benzinga Newsdesk Today, 4:08 AM Wells Fargo analyst Ike Boruchow upgrades Stitch Fix (NASDAQ:SFIX) from Underweight to Equal-Weight and announces $4 price target. SFIX
Read More 1 minute read Analyst Ratings News Price Target Upgrades Cowen & Co. Upgrades Molson Coors Beverage to Outperform, Raises Price Target to $60 By Benzinga Newsdesk Today, 4:08 AM Cowen & Co. analyst Vivien Azer upgrades Molson Coors Beverage (NYSE:TAP) from Market Perform to Outperform and raises the price target from $55 to $60. TAP
Read More 1 minute read Analyst Ratings News Price Target Upgrades Wells Fargo Upgrades Sunrun to Overweight, Announces $32 Price Target By Benzinga Newsdesk Today, 4:08 AM Wells Fargo analyst Michael Blum upgrades Sunrun (NASDAQ:RUN) from Equal-Weight to Overweight and announces $32 price target. RUN
Read More 1 minute read Analyst Ratings News Price Target Upgrades Jefferies Upgrades Aligos Therapeutics to Buy, Raises Price Target to $3 By Benzinga Newsdesk Today, 4:08 AM Jefferies analyst Michael Yee upgrades Aligos Therapeutics (NASDAQ:ALGS) from Hold to Buy and raises the price target from $2.5 to $3. ALGS
Read More 1 minute read Analyst Ratings News Price Target Upgrades Jefferies Upgrades Amarin Corp to Buy, Raises Price Target to $3 By Benzinga Newsdesk Today, 4:08 AM Jefferies analyst Michael Yee upgrades Amarin Corp (NASDAQ:AMRN) from Hold to Buy and raises the price target from $1.3 to $3. AMRN
Read More 1 minute read Analyst Ratings News Price Target Upgrades Piper Sandler Upgrades Zynex to Overweight, Raises Price Target to $18 By Benzinga Newsdesk Today, 4:08 AM Piper Sandler analyst Adam Maeder upgrades Zynex (NASDAQ:ZYXI) from Neutral to Overweight and raises the price target from $10 to $18. ZYXI
Read More 1 minute read Analyst Ratings News Price Target Upgrades Baird Upgrades Regency Centers to Outperform, Announces $71 Price Target By Benzinga Newsdesk Today, 4:08 AM Baird analyst Wesley Golladay upgrades Regency Centers (NASDAQ:REG) from Neutral to Outperform and announces $71 price target. REG
Read More 1 minute read Analyst Ratings News Upgrades JonesTrading Upgrades Deciphera Pharmaceuticals to Hold By Benzinga Newsdesk Today, 4:08 AM JonesTrading analyst Soumit Roy upgrades Deciphera Pharmaceuticals (NASDAQ:DCPH) from Sell to Hold. DCPH